Subtitle
Improve dosimetric outcome in stage III NSCLC treatment using SPArc therapy
Subtitle
Improve dosimetric outcome in stage III NSCLC treatment using SPArc therapy
Proto therapy Time
December 2018
Check full study
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
Comparison of robustly optimised SPArc and IMPT plans suggests that Arc-PT treatment plans seem to be more robust against breathing motion than IMPT plans, reducing the interplay effect, the cold and hot spots caused by motion of the target as well as the integral body dose.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
July 2024
Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy.
Webinar
Motion Management – Overview
Soufian
Audia
Webinar
April 22, 2022
Managing Organ Motion
Mark
Pankuch
Proton Therapy Publication
July 2022
Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020.
Proton Therapy Publication
October 2021
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.
Webinar
May 17, 2021
New developments in PT: Motion Management, DynamicARC® and ConformalFLASH®
Alonso
Gutierrez
Swati
Girdhani
Webinar
November 20, 2020
Managing motion in PT
Erik
Korevaar
Peng
Wang
Proton Therapy Publication
23 July 2020
Evaluation of interplay and organ motion effects by means of 4D dose reconstruction and accumulation
Proton Therapy Publication
March 2020
The role of breath hold intensity modulated proton therapy for a case ofleft-sided breast cancer with IMN involvement. How protons compare with other conformal techniques